In a primary central nervous system lymphoma (PCNSL) mouse model treated with CD19-directed CAR-T cells either by intratumoral or i.v. injection, a successful eradication of the large established tumor was observed in the intratumoral, but not the i.v. route of administration [49]. This evidence concerns the gene CD19 and primary central nervous system lymphoma.